Cargando…
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
PURPOSE: A germline microRNA binding site-disrupting variant, the KRAS-variant (rs61764370), is associated with an increased risk of developing several cancers. Because this variant is most strongly associated with ovarian cancer risk in patients from hereditary breast and ovarian families (HBOC), a...
Autores principales: | Pilarski, Robert, Patel, Divya A., Weitzel, Jeffrey, McVeigh, Terri, Dorairaj, Jemima J., Heneghan, Helen M., Miller, Nicola, Weidhaas, Joanne B., Kerin, Michael J., McKenna, Megan, Wu, Xifeng, Hildebrandt, Michelle, Zelterman, Daniel, Sand, Sharon, Shulman, Lee P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360659/ https://www.ncbi.nlm.nih.gov/pubmed/22662244 http://dx.doi.org/10.1371/journal.pone.0037891 |
Ejemplares similares
-
Estrogen withdrawal, increased breast cancer risk and the KRAS-variant
por: McVeigh, Terri P, et al.
Publicado: (2015) -
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
por: McVeigh, Terri P, et al.
Publicado: (2017) -
A germline mutation in the BRCA1 3’UTR predicts Stage IV breast cancer
por: Dorairaj, Jemima J, et al.
Publicado: (2014) -
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults
por: McVeigh, Una Mary, et al.
Publicado: (2021) -
Investigating the association of rs2910164 with cancer predisposition in an Irish cohort
por: McVeigh, T P, et al.
Publicado: (2017)